The global biotechnology tools market is driven by advancements in genomic research, proteomics, and the increasing adoption of molecular diagnostics in clinical and research applications. The rise in the prevalence of chronic and genetic diseases has significantly propelled the demand for advanced biotechnological tools. For instance, the World Health Organization (WHO) estimates that approximately 10 million people globally succumb to cancer annually, highlighting the growing need for tools such as NGS and PCR in early diagnosis and precision treatment. Additionally, increasing agricultural biotechnology adoption to enhance crop yield and resistance has augmented the market growth. The rapid advancements in bioinformatics and computational biology further bolster the market, providing critical support for drug discovery and personalized medicine initiatives.
